Skip to main content
  • Saved

made a Post

Consensus statement on the current pharmacological prevention and management of heart failure - PubMed

Consensus statement on the current pharmacological prevention and management of heart failure - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/35908234/

▪Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to prevent hospitalisation for heart failure in type 2 diabetes mellitus can be extended to patients with multiple cardiovascular risk factors, albuminuric chronic kidney disease, or atherosclerotic cardiovascular disease. ▪New evidence suppo ...



Main recommendations: Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to prevent hospitalisation for heart failure in type 2 diabetes mellitus can be extended to patients with multiple cardiovascular risk factors, albuminuric chronic kidney disease, or atherosclerotic cardiovascular disease ….